Glucagon, GLP-1 co-infusion can reduce appetite

June 25, 2014
Glucagon, GLP-1 co-infusion can reduce appetite

(HealthDay)—Co-infusion of glucagon and glucagon-like peptide 1 (GLP-1) correlates with a reduction in appetite, and GLP-1 protects against glucagon-induced hyperglycemia in healthy volunteers, according to a study published online June 17 in Diabetes.

Jaimini Cegla, M.B.B.S., from Imperial College London in the United Kingdom, and colleagues conducted a double-blind, cross-over study involving 13 human volunteers to examine the effect of administration of a combination of glucagon and GLP-1. Sub-anorectic doses of each peptide alone, in combination, or placebo were infused into volunteers for 120 minutes. After 90 minutes, an ad libitum meal was provided, and was determined.

The researchers found that there was no significant reduction in with either glucagon or GLP-1 given individually. Co-infusion led to a significant 13 percent reduction in food intake. The addition of GLP-1 also offered protection against glucagon-induced hyperglycemia; co-infusion correlated with a 53kcal/day increase in energy expenditure.

"These observations support the concept of GLP-1 and glucagon dual agonism as a possible treatment for obesity and diabetes," the authors write.

Explore further: Diet soda linked to increase in glucagon-like peptide 1 levels

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Importance of diabetes genetic variants unclear

April 4, 2012

(HealthDay) -- Genetic variants associated with type 2 diabetes that affect glucagon-like peptide 1 (GLP-1) are not associated with GLP-1 levels or GLP-1-induced insulin secretion in healthy individuals, according to a study ...

High-fat diet impairs satiation signaling in obese-prone

February 27, 2013

(HealthDay)—Feeding obese-prone rats a high-fat diet leads to impaired satiation signaling through glucagon-like peptide-1 (GLP-1), a gastrointestinal hormone that suppresses food intake and helps regulate energy balance, ...

Artificial sweeteners produce no glucagon response

January 14, 2014

(HealthDay)—Artificial sweeteners do not produce any changes in glucose metabolism compared to a glass of water, according to a letter published in the December issue of Diabetes Care.

Recommended for you

Diets avoiding dry-cooked foods can protect against diabetes

August 24, 2016

Simple changes in how we cook could go a long way towards preventing diabetes, say researchers at the Icahn School of Medicine at Mount Sinai. A new randomized controlled trial, published online July 29 in the journal Diabetologia, ...

New study reveals a novel protein linked to type 2 diabetes

August 16, 2016

Findings from Boston University School of Medicine (BUSM), which appear in eLife, provide a possible explanation as to why most people who are obese develop insulin resistance and type 2 diabetes. A minority of obese individuals, ...

Bacteria may cause type 2 diabetes

June 1, 2015

Bacteria and viruses have an obvious role in causing infectious diseases, but microbes have also been identified as the surprising cause of other illnesses, including cervical cancer (Human papilloma virus) and stomach ulcers ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.